Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.18 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 39.71.
Market Cap
8.18T
Revenue
4.52T
Profits
206.11B
PE Ratio
39.71
Profit Margin
4.56%
Dividend Yield
0.45%
1065 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 821.44B | 3.54% | 1,465,797 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 585.65B | 0.27% | 2,918,493 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 383.56B | 1.75% | 3,664,998 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 300.74B | 0.64% | 1,804,559 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 296.54B | 1.56% | 4,731,638 | 65.01B |
| 6 | NVS | Novartis AG | 285.70B | 1.00% | 885,490 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 245.15B | 3.17% | 4,703,778 | 447.57B |
| 8 | AMGN | Amgen Inc. | 189.61B | 0.79% | 1,225,720 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 181.92B | 2.01% | 830,996 | 44.56B |
| 10 | ABT | Abbott Laboratories | 177.79B | 0.20% | 5,568,440 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 171.47B | 1.33% | 2,697,947 | 29.44B |
| 12 | ISRG | Intuitive Surgical, Inc. | 163.74B | 1.82% | 762,493 | 10.06B |
| 13 | PFE | Pfizer Inc. | 158.59B | 0.40% | 23,864,942 | 62.58B |
| 14 | NVO | Novo Nordisk A/S | 158.15B | 2.73% | 11,835,276 | 48.59B |
| 15 | DHR | Danaher Corporation | 134.12B | 3.06% | 2,139,354 | 24.57B |
| 16 | SYK | Stryker Corporation | 124.79B | - | 1,075,808 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 123.18B | 1.00% | 4,973,953 | 48.19B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 113.46B | 0.78% | 511,093 | 12.00B |
| 19 | SNY | Sanofi | 113.27B | 2.44% | 1,279,673 | 54.85B |
| 20 | MDT | Medtronic plc | 110.53B | 0.41% | 3,282,965 | 35.48B |
| 21 | GSK | GSK plc | 108.78B | 1.07% | 3,746,817 | 43.97B |
| 22 | MCK | McKesson Corporation | 105.12B | -0.23% | 385,371 | 397.96B |
| 23 | HCA | HCA Healthcare, Inc. | 104.49B | -0.10% | 323,014 | 75.60B |
| 24 | BSX | Boston Scientific Corporation | 92.45B | -1.14% | 15,735,732 | 20.07B |
| 25 | CVS | CVS Health Corporation | 91.51B | 2.55% | 2,626,326 | 399.83B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.04B | 2.79% | 233,230 | 14.34B |
| 27 | CI | The Cigna Group | 70.13B | 3.07% | 622,496 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 64.30B | 2.78% | 545,785 | 199.13B |
| 29 | COR | Cencora, Inc. | 60.35B | 0.10% | 695,066 | 325.78B |
| 30 | MDLN | Medline Inc. | 57.54B | 2.77% | 5,778,160 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 56.28B | 1.04% | 3,081,838 | 28.48B |
| 32 | ZTS | Zoetis Inc. | 49.59B | 0.98% | 1,563,886 | 9.47B |
| 33 | CAH | Cardinal Health, Inc. | 49.34B | 1.64% | 517,536 | 244.67B |
| 34 | EW | Edwards Lifesciences Corporation | 45.93B | 0.21% | 2,118,927 | 6.07B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 44.73B | 0.85% | 370,933 | 4.30B |
| 36 | BDX | Becton, Dickinson and Company | 44.56B | 1.17% | 695,365 | 21.92B |
| 37 | HLN | Haleon plc | 44.26B | -0.40% | 9,077,116 | 14.85B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.90B | 4.72% | 617,553 | 3.71B |
| 39 | ARGX | argenx SE | 43.57B | 3.28% | 224,946 | 4.24B |
| 40 | ALC | Alcon Inc. | 36.18B | 1.28% | 836,319 | 10.40B |
| 41 | INSM | Insmed Incorporated | 35.22B | 6.57% | 1,769,818 | 606.42M |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 34.28B | 3.81% | 2,613,403 | 17.26B |
| 43 | ONC | BeOne Medicines AG | 32.61B | 3.52% | 126,918 | 5.34B |
| 44 | RMD | ResMed Inc. | 32.53B | 1.94% | 355,518 | 5.40B |
| 45 | GEHC | GE HealthCare Technologies Inc. | 32.30B | 2.94% | 1,506,194 | 20.63B |
| 46 | A | Agilent Technologies, Inc. | 32.21B | 1.75% | 720,270 | 7.07B |
| 47 | WAT | Waters Corporation | 29.20B | 1.46% | 465,523 | 3.17B |
| 48 | VEEV | Veeva Systems Inc. | 28.64B | -0.35% | 792,560 | 3.20B |
| 49 | IQV | IQVIA Holdings Inc. | 28.52B | 2.23% | 571,590 | 16.31B |
| 50 | NTRA | Natera, Inc. | 27.98B | 5.68% | 525,041 | 2.31B |
| 51 | RPRX | Royalty Pharma plc | 27.39B | 2.38% | 1,355,972 | 2.38B |
| 52 | BIIB | Biogen Inc. | 26.43B | -3.99% | 1,660,000 | 9.89B |
| 53 | MTD | Mettler-Toledo International Inc. | 25.70B | 1.71% | 64,193 | 4.03B |
| 54 | UTHR | United Therapeutics Corporation | 25.63B | -0.61% | 431,465 | 3.18B |
| 55 | PHG | Koninklijke Philips N.V. | 25.50B | 2.56% | 641,924 | 20.94B |
| 56 | DXCM | DexCom, Inc. | 24.39B | 2.39% | 1,771,899 | 4.66B |
| 57 | LH | Labcorp Holdings Inc. | 21.72B | -0.02% | 350,778 | 13.95B |
| 58 | STE | STERIS plc | 21.59B | 0.35% | 221,140 | 5.83B |
| 59 | BNTX | BioNTech SE | 21.39B | 4.57% | 459,453 | 3.37B |
| 60 | DGX | Quest Diagnostics Incorporated | 21.34B | -1.48% | 394,281 | 11.04B |
| 61 | HUM | Humana Inc. | 20.70B | 3.86% | 494,491 | 129.66B |
| 62 | ROIV | Roivant Sciences Ltd. | 19.93B | 5.41% | 2,432,197 | 13.31M |
| 63 | MRNA | Moderna, Inc. | 19.90B | 4.02% | 4,608,304 | 1.94B |
| 64 | RVMD | Revolution Medicines, Inc. | 19.24B | 4.74% | 1,513,182 | - |
| 65 | ILMN | Illumina, Inc. | 18.85B | 2.05% | 525,242 | 4.34B |
| 66 | INCY | Incyte Corporation | 18.60B | 3.47% | 511,616 | 5.14B |
| 67 | WST | West Pharmaceutical Services, Inc. | 18.10B | 2.51% | 315,878 | 3.07B |
| 68 | ZBH | Zimmer Biomet Holdings, Inc. | 17.58B | 1.40% | 695,701 | 8.23B |
| 69 | HOLX | Hologic, Inc. | 16.87B | 0.03% | 938,379 | 4.13B |
| 70 | GMAB | Genmab A/S | 16.22B | 3.48% | 648,701 | 3.72B |
| 71 | THC | Tenet Healthcare Corporation | 16.08B | -1.62% | 874,936 | 21.31B |
| 72 | CNC | Centene Corporation | 15.97B | 2.14% | 2,036,433 | 176.15B |
| 73 | VTRS | Viatris Inc. | 15.43B | 3.40% | 2,410,119 | 14.30B |
| 74 | PODD | Insulet Corporation | 14.78B | 0.95% | 254,841 | 2.71B |
| 75 | SMMT | Summit Therapeutics Inc. | 14.50B | 10.13% | 1,898,337 | - |
| 76 | BBIO | BridgeBio Pharma, Inc. | 14.36B | 6.78% | 1,002,000 | 502.08M |
| 77 | ASND | Ascendis Pharma A/S | 14.08B | 5.08% | 339,463 | 845.52M |
| 78 | COO | The Cooper Companies, Inc. | 13.87B | 2.54% | 636,643 | 4.15B |
| 79 | MEDP | Medpace Holdings, Inc. | 13.60B | 4.08% | 115,321 | 2.53B |
| 80 | SNN | Smith & Nephew plc | 13.46B | 0.19% | 352,479 | 6.16B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 13.31B | 3.01% | 357,583 | 2.86B |
| 82 | PEN | Penumbra, Inc. | 12.85B | -0.20% | 489,526 | 1.40B |
| 83 | RGC | Regencell Bioscience Holdings Limited | 12.71B | 10.16% | 51,351 | - |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 12.41B | 3.61% | 833,189 | 943.71M |
| 85 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.30B | 6.08% | 297,136 | 958.40M |
| 86 | ALGN | Align Technology, Inc. | 12.12B | 2.27% | 338,719 | 4.03B |
| 87 | FMS | Fresenius Medical Care AG | 12.07B | 0.77% | 245,799 | 23.05B |
| 88 | GH | Guardant Health, Inc. | 12.00B | 6.16% | 1,370,487 | 982.02M |
| 89 | ELAN | Elanco Animal Health Incorporated | 11.86B | 1.75% | 2,019,150 | 4.72B |
| 90 | GMED | Globus Medical, Inc. | 11.62B | 2.84% | 611,774 | 2.94B |
| 91 | JAZZ | Jazz Pharmaceuticals plc | 11.55B | 2.45% | 535,503 | 4.27B |
| 92 | ENSG | The Ensign Group, Inc. | 11.52B | -0.33% | 186,095 | 5.06B |
| 93 | SOLV | Solventum Corporation | 11.30B | 2.68% | 819,602 | 8.33B |
| 94 | EXEL | Exelixis, Inc. | 11.11B | 2.00% | 758,401 | 2.32B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 11.06B | 2.30% | 996,676 | 3.85B |
| 96 | UHS | Universal Health Services, Inc. | 10.86B | -2.36% | 285,948 | 17.36B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.74B | 1.90% | 1,384,457 | 3.22B |
| 98 | DVA | DaVita Inc. | 10.23B | 0.54% | 242,888 | 13.64B |
| 99 | RVTY | Revvity, Inc. | 9.79B | 3.27% | 491,283 | 2.86B |
| 100 | EHC | Encompass Health Corporation | 9.53B | -1.66% | 342,488 | 5.94B |
| 101 | MASI | Masimo Corporation | 9.28B | 0.27% | 755,103 | 1.53B |
| 102 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.75B | 8.38% | 1,087,068 | 1.09B |
| 103 | AXSM | Axsome Therapeutics, Inc. | 8.75B | 6.52% | 364,668 | 638.50M |
| 104 | PRAX | Praxis Precision Medicines, Inc. | 8.74B | 13.48% | 441,528 | 7.46M |
| 105 | BTSG | BrightSpring Health Services, Inc. | 8.66B | 2.12% | 942,378 | 12.91B |
| 106 | BAX | Baxter International Inc. | 8.63B | 5.82% | 4,664,162 | 11.24B |
| 107 | ABVX | ABIVAX Société Anonyme | 8.55B | 10.05% | 900,172 | 5.37M |
| 108 | HSIC | Henry Schein, Inc. | 8.41B | 0.91% | 398,502 | 13.18B |
| 109 | ICLR | ICON Public Limited Company | 8.40B | 4.66% | 510,615 | 8.10B |
| 110 | CRL | Charles River Laboratories International, Inc. | 8.38B | 6.55% | 423,326 | 4.02B |
| 111 | PCVX | Vaxcyte, Inc. | 8.29B | 4.86% | 872,318 | - |
| 112 | QGEN | Qiagen N.V. | 8.25B | 1.84% | 550,997 | 2.09B |
| 113 | TECH | Bio-Techne Corporation | 8.19B | 0.56% | 1,179,377 | 1.22B |
| 114 | CYTK | Cytokinetics, Incorporated | 8.11B | 4.51% | 839,702 | 88.04M |
| 115 | TEM | Tempus AI, Inc. | 8.09B | 6.82% | 2,750,163 | 1.27B |
| 116 | ATR | AptarGroup, Inc. | 8.06B | 2.41% | 302,298 | 3.78B |
| 117 | NUVL | Nuvalent, Inc. | 8.02B | 5.52% | 541,573 | - |
| 118 | IBRX | ImmunityBio, Inc. | 7.82B | 14.19% | 16,216,104 | 113.29M |
| 119 | HALO | Halozyme Therapeutics, Inc. | 7.61B | 3.41% | 599,645 | 1.40B |
| 120 | KRYS | Krystal Biotech, Inc. | 7.55B | 4.53% | 177,574 | 389.13M |
| 121 | BIO | Bio-Rad Laboratories, Inc. | 7.48B | 2.54% | 58,412 | 2.58B |
| 122 | HQY | HealthEquity, Inc. | 7.02B | 1.99% | 398,799 | 1.31B |
| 123 | MOH | Molina Healthcare, Inc. | 6.97B | 1.71% | 555,658 | 43.56B |
| 124 | KYMR | Kymera Therapeutics, Inc. | 6.80B | 4.81% | 812,854 | 39.21M |
| 125 | ACLX | Arcellx, Inc. | 6.73B | -0.09% | 525,239 | 22.29M |
| 126 | PTGX | Protagonist Therapeutics, Inc. | 6.64B | 4.21% | 303,640 | 46.02M |
| 127 | RGEN | Repligen Corporation | 6.59B | 4.97% | 593,872 | 738.26M |
| 128 | BLTE | Belite Bio, Inc | 6.29B | 7.19% | 137,647 | - |
| 129 | GKOS | Glaukos Corporation | 6.26B | 2.74% | 194,405 | 507.44M |
| 130 | GRFS | Grifols, S.A. | 6.25B | 5.03% | 658,033 | 8.83B |
| 131 | COGT | Cogent Biosciences, Inc. | 6.20B | 8.70% | 2,675,145 | - |
| 132 | APGE | Apogee Therapeutics, Inc. | 6.17B | 6.21% | 513,992 | - |
| 133 | TERN | Terns Pharmaceuticals, Inc. | 6.09B | -0.27% | 7,778,335 | - |
| 134 | CNTA | Centessa Pharmaceuticals plc | 5.83B | 44.67% | 35,784,560 | 15.00M |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.80B | 9.98% | 1,249,861 | 189.76M |
| 136 | ALKS | Alkermes plc | 5.76B | 14.99% | 8,429,333 | 1.48B |
| 137 | CGON | CG Oncology, Inc. | 5.69B | 5.33% | 1,024,636 | 4.04M |
| 138 | PTCT | PTC Therapeutics, Inc. | 5.63B | 3.54% | 306,699 | 1.73B |
| 139 | MIRM | Mirum Pharmaceuticals, Inc. | 5.61B | 5.80% | 796,777 | 521.31M |
| 140 | BLCO | Bausch + Lomb Corporation | 5.59B | 3.47% | 260,806 | 5.10B |
| 141 | XENE | Xenon Pharmaceuticals Inc. | 5.55B | 4.68% | 799,949 | 7.50M |
| 142 | SRRK | Scholar Rock Holding Corporation | 5.49B | 11.00% | 2,778,206 | - |
| 143 | CELC | Celcuity Inc. | 5.47B | 4.51% | 234,491 | - |
| 144 | BRKR | Bruker Corporation | 5.44B | 4.08% | 792,427 | 3.44B |
| 145 | AVTR | Avantor, Inc. | 5.31B | 2.50% | 2,557,678 | 6.55B |
| 146 | TFX | Teleflex Incorporated | 5.22B | 2.75% | 307,079 | 1.99B |
| 147 | CHE | Chemed Corporation | 5.21B | 1.24% | 113,488 | 2.53B |
| 148 | APLS | Apellis Pharmaceuticals, Inc. | 5.15B | 135.61% | 74,796,349 | 1.00B |
| 149 | IMVT | Immunovant, Inc. | 5.03B | 5.01% | 808,754 | - |
| 150 | CAI | Caris Life Sciences, Inc. | 5.02B | 5.52% | 1,711,018 | 812.03M |
| 151 | PACS | PACS Group, Inc. | 4.98B | 4.33% | 345,173 | 5.29B |
| 152 | TGTX | TG Therapeutics, Inc. | 4.95B | 6.47% | 1,816,417 | 616.29M |
| 153 | ERAS | Erasca, Inc. | 4.92B | 5.89% | 2,194,329 | - |
| 154 | LNTH | Lantheus Holdings, Inc. | 4.87B | 2.57% | 226,152 | 1.54B |
| 155 | HIMS | Hims & Hers Health, Inc. | 4.70B | 9.90% | 24,133,760 | 2.35B |
| 156 | WAY | Waystar Holding Corp. | 4.55B | 1.19% | 1,341,664 | 1.10B |
| 157 | FOLD | Amicus Therapeutics, Inc. | 4.53B | 0.03% | 1,061,694 | 634.21M |
| 158 | CRSP | CRISPR Therapeutics AG | 4.49B | 5.55% | 1,008,474 | 3.51M |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 4.45B | 5.90% | 1,080,995 | 2.04M |
| 160 | RDNT | RadNet, Inc. | 4.37B | 1.05% | 415,134 | 2.04B |
| 161 | DOCS | Doximity, Inc. | 4.32B | -1.54% | 3,720,095 | 637.78M |
| 162 | CORT | Corcept Therapeutics Incorporated | 4.22B | 4.04% | 727,043 | 761.41M |
| 163 | OPCH | Option Care Health, Inc. | 4.19B | -0.85% | 816,068 | 5.65B |
| 164 | MMED | Minimed Group, Inc. | 4.16B | 3.28% | 855,777 | 2.89B |
| 165 | NVST | Envista Holdings Corporation | 4.14B | 4.12% | 865,883 | 2.72B |
| 166 | MMSI | Merit Medical Systems, Inc. | 4.07B | -0.24% | 270,569 | 1.52B |
| 167 | SHC | Sotera Health Company | 4.05B | 7.58% | 3,377,094 | 1.16B |
| 168 | AMRX | Amneal Pharmaceuticals, Inc. | 3.93B | 3.01% | 389,046 | 3.02B |
| 169 | LGND | Ligand Pharmaceuticals Incorporated | 3.92B | 2.05% | 97,518 | 268.09M |
| 170 | SYRE | Spyre Therapeutics, Inc. | 3.92B | 9.80% | 491,090 | - |
| 171 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.84B | 7.09% | 707,068 | 7.70M |
| 172 | IRTC | iRhythm Holdings, Inc. | 3.83B | 3.76% | 234,170 | 747.14M |
| 173 | STVN | Stevanato Group S.p.A. | 3.79B | 3.19% | 421,145 | 1.39B |
| 174 | ACAD | ACADIA Pharmaceuticals Inc. | 3.77B | 5.08% | 929,138 | 1.07B |
| 175 | VKTX | Viking Therapeutics, Inc. | 3.77B | 9.09% | 1,538,359 | - |
| 176 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.68B | 5.34% | 246,908 | 677.56M |
| 177 | NAMS | NewAmsterdam Pharma Company N.V. | 3.63B | 7.50% | 1,062,231 | 22.50M |
| 178 | ALHC | Alignment Healthcare, Inc. | 3.56B | 3.50% | 1,574,769 | 3.95B |
| 179 | BLLN | BillionToOne, Inc. | 3.53B | 9.66% | 118,074 | 305.11M |
| 180 | LIVN | LivaNova PLC | 3.44B | 2.69% | 526,970 | 1.39B |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 3.43B | 5.58% | 348,794 | - |
| 182 | TMDX | TransMedics Group, Inc. | 3.40B | 5.08% | 616,681 | 605.49M |
| 183 | OSCR | Oscar Health, Inc. | 3.39B | 5.16% | 3,403,350 | 11.70B |
| 184 | LEGN | Legend Biotech Corporation | 3.34B | 4.39% | 720,039 | 1.03B |
| 185 | GPCR | Structure Therapeutics Inc. | 3.31B | 6.24% | 845,321 | - |
| 186 | LQDA | Liquidia Corporation | 3.30B | 6.59% | 696,267 | 158.32M |
| 187 | BKD | Brookdale Senior Living Inc. | 3.24B | 1.72% | 7,290,224 | 3.05B |
| 188 | ICUI | ICU Medical, Inc. | 3.19B | 1.93% | 85,573 | 2.23B |
| 189 | TLX | Telix Pharmaceuticals Limited | 3.17B | 6.14% | 85,642 | 803.79M |
| 190 | HNGE | Hinge Health, Inc. | 3.03B | 4.68% | 458,019 | 587.86M |
| 191 | DNLI | Denali Therapeutics Inc. | 3.03B | 5.64% | 1,055,227 | - |
| 192 | TARS | Tarsus Pharmaceuticals, Inc. | 3.02B | 6.04% | 370,285 | 451.36M |
| 193 | ITGR | Integer Holdings Corporation | 3.01B | 2.80% | 158,241 | 1.85B |
| 194 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.99B | 2.94% | 303,020 | 588.99M |
| 195 | SUPN | Supernus Pharmaceuticals, Inc. | 2.97B | 4.38% | 165,137 | 718.95M |
| 196 | TNGX | Tango Therapeutics, Inc. | 2.95B | 7.50% | 1,823,788 | 62.38M |
| 197 | DYN | Dyne Therapeutics, Inc. | 2.94B | 4.27% | 1,057,285 | - |
| 198 | IDYA | IDEAYA Biosciences, Inc. | 2.92B | 5.63% | 503,660 | 218.71M |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 2.89B | 9.40% | 999,470 | 376.07M |
| 200 | TWST | Twist Bioscience Corporation | 2.83B | 6.87% | 554,983 | 391.56M |
| 201 | ALMS | Alumis Inc. | 2.83B | 9.95% | 1,370,773 | 24.05M |
| 202 | VERA | Vera Therapeutics, Inc. | 2.82B | 3.65% | 1,020,849 | - |
| 203 | PBH | Prestige Consumer Healthcare Inc. | 2.77B | 0.15% | 145,770 | 1.10B |
| 204 | CON | Concentra Group Holdings Parent, Inc. | 2.72B | 0.55% | 214,399 | 2.16B |
| 205 | RCUS | Arcus Biosciences, Inc. | 2.70B | 4.46% | 361,165 | 247.00M |
| 206 | TVTX | Travere Therapeutics, Inc. | 2.69B | 5.50% | 968,100 | 490.73M |
| 207 | TXG | 10x Genomics, Inc. | 2.65B | 4.80% | 1,507,224 | 642.82M |
| 208 | HAE | Haemonetics Corporation | 2.62B | 2.66% | 211,329 | 1.32B |
| 209 | VCYT | Veracyte, Inc. | 2.56B | 5.98% | 551,645 | 517.15M |
| 210 | WRBY | Warby Parker Inc. | 2.56B | 2.80% | 1,145,937 | 871.91M |
| 211 | PRVA | Privia Health Group, Inc. | 2.53B | 2.15% | 237,510 | 2.12B |
| 212 | NHC | National HealthCare Corporation | 2.49B | -1.47% | 78,853 | 1.52B |
| 213 | LMAT | LeMaitre Vascular, Inc. | 2.48B | 1.93% | 112,365 | 249.60M |
| 214 | IMNM | Immunome, Inc. | 2.47B | 13.21% | 1,741,627 | 6.94M |
| 215 | HCM | HUTCHMED (China) Limited | 2.45B | 4.34% | 18,440 | 548.51M |
| 216 | IRON | Disc Medicine, Inc. | 2.44B | 5.36% | 173,500 | - |
| 217 | KOD | Kodiak Sciences Inc. | 2.44B | 17.05% | 1,766,834 | - |
| 218 | LFST | LifeStance Health Group, Inc. | 2.44B | 0.32% | 691,343 | 1.42B |
| 219 | ORKA | Oruka Therapeutics, Inc. | 2.42B | 7.51% | 589,470 | - |
| 220 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.38B | 0.58% | 2,706,290 | 874.84M |
| 221 | BEAM | Beam Therapeutics Inc. | 2.38B | 9.45% | 1,468,452 | 139.74M |
| 222 | GRDN | Guardian Pharmacy Services, Inc. | 2.37B | 0.48% | 457,566 | 1.45B |
| 223 | MANE | Veradermics, Incorporated | 2.34B | 2.97% | 443,144 | - |
| 224 | ELVN | Enliven Therapeutics, Inc. | 2.32B | 5.82% | 1,418,186 | - |
| 225 | XRAY | DENTSPLY SIRONA Inc. | 2.29B | 2.41% | 2,755,509 | 3.68B |
| 226 | SRPT | Sarepta Therapeutics, Inc. | 2.28B | 6.01% | 1,163,956 | 2.20B |
| 227 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | 0.07% | 400,915 | 158.18M |
| 228 | MLYS | Mineralys Therapeutics, Inc. | 2.21B | 13.95% | 1,549,097 | - |
| 229 | PAHC | Phibro Animal Health Corporation | 2.19B | 1.50% | 116,138 | 1.46B |
| 230 | ADMA | ADMA Biologics, Inc. | 2.16B | -0.66% | 3,320,035 | 510.17M |
| 231 | AAPG | Ascentage Pharma Group International | 2.16B | 1.51% | 2,038 | 82.08M |
| 232 | CLDX | Celldex Therapeutics, Inc. | 2.14B | 9.06% | 988,147 | 1.55M |
| 233 | ACHC | Acadia Healthcare Company, Inc. | 2.12B | 0.88% | 819,008 | 3.31B |
| 234 | ADPT | Adaptive Biotechnologies Corporation | 2.10B | 5.91% | 751,726 | 276.98M |
| 235 | ZLAB | Zai Lab Limited | 2.10B | 4.20% | 363,677 | 460.16M |
| 236 | GRAL | GRAIL, Inc. | 2.09B | 8.81% | 277,468 | 147.17M |
| 237 | HTFL | HeartFlow, Inc. | 2.08B | 1.63% | 801,719 | 176.03M |
| 238 | SNDX | Syndax Pharmaceuticals, Inc. | 2.05B | 3.60% | 1,083,954 | 172.35M |
| 239 | AGIO | Agios Pharmaceuticals, Inc. | 2.05B | 18.10% | 2,260,942 | 54.03M |
| 240 | TYRA | Tyra Biosciences, Inc. | 2.03B | 9.05% | 839,187 | - |
| 241 | RARE | Ultragenyx Pharmaceutical Inc. | 2.03B | 7.20% | 936,166 | 673.00M |
| 242 | SEM | Select Medical Holdings Corporation | 2.02B | - | 455,812 | 5.45B |
| 243 | AHG | Akso Health Group | 2.01B | - | 144,931 | 14.84M |
| 244 | NEOG | Neogen Corporation | 1.99B | 2.69% | 713,191 | 880.32M |
| 245 | GLPG | Galapagos NV | 1.99B | 5.20% | 96,590 | 1.31B |
| 246 | NKTR | Nektar Therapeutics | 1.99B | 6.22% | 773,303 | 55.23M |
| 247 | BHC | Bausch Health Companies Inc. | 1.98B | 6.06% | 852,042 | 10.27B |
| 248 | VRDN | Viridian Therapeutics, Inc. | 1.96B | 3.67% | 2,522,793 | 70.85M |
| 249 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | 5.51% | 832,121 | 283.06M |
| 250 | STOK | Stoke Therapeutics, Inc. | 1.93B | 2.49% | 586,289 | 184.42M |
| 251 | MESO | Mesoblast Limited | 1.91B | 6.12% | 125,690 | 65.38M |
| 252 | WGS | GeneDx Holdings Corp. | 1.88B | 7.67% | 334,869 | 427.54M |
| 253 | DFTX | Definium Therapeutics, Inc. | 1.87B | 7.14% | 1,519,563 | - |
| 254 | PHVS | Pharvaris N.V. | 1.83B | 3.37% | 352,111 | - |
| 255 | ZYME | Zymeworks Inc. | 1.83B | 2.42% | 172,932 | 105.97M |
| 256 | SION | Sionna Therapeutics, Inc. | 1.81B | 9.82% | 218,007 | - |
| 257 | OCUL | Ocular Therapeutix, Inc. | 1.81B | 12.30% | 2,803,204 | 51.95M |
| 258 | SLNO | Soleno Therapeutics, Inc. | 1.75B | 11.14% | 1,836,582 | 190.41M |
| 259 | RLAY | Relay Therapeutics, Inc. | 1.75B | 4.49% | 916,271 | 15.36M |
| 260 | AORT | Artivion, Inc. | 1.73B | 1.86% | 162,816 | 441.33M |
| 261 | CAPR | Capricor Therapeutics, Inc. | 1.72B | 7.78% | 797,364 | 11.13M |
| 262 | MD | Pediatrix Medical Group, Inc. | 1.72B | 1.73% | 468,872 | 1.91B |
| 263 | INVA | Innoviva, Inc. | 1.72B | 1.11% | 261,421 | 411.33M |
| 264 | ADUS | Addus HomeCare Corporation | 1.70B | -0.48% | 96,585 | 1.42B |
| 265 | AXGN | Axogen, Inc. | 1.70B | 4.66% | 433,997 | 225.21M |
| 266 | PVLA | Palvella Therapeutics, Inc. | 1.69B | 13.86% | 286,835 | - |
| 267 | ATEC | Alphatec Holdings, Inc. | 1.68B | 0.82% | 1,050,877 | 764.16M |
| 268 | ESTA | Establishment Labs Holdings Inc. | 1.64B | 2.42% | 211,438 | 211.08M |
| 269 | HRMY | Harmony Biosciences Holdings, Inc. | 1.62B | 3.81% | 351,642 | 868.45M |
| 270 | VCEL | Vericel Corporation | 1.61B | 3.54% | 481,031 | 276.26M |
| 271 | AHCO | AdaptHealth Corp. | 1.61B | 4.96% | 1,316,385 | 3.24B |
| 272 | ANAB | AnaptysBio, Inc. | 1.61B | 1.08% | 456,621 | 234.60M |
| 273 | RXRX | Recursion Pharmaceuticals, Inc. | 1.61B | 7.04% | 9,118,842 | 74.68M |
| 274 | NRIX | Nurix Therapeutics, Inc. | 1.60B | 5.56% | 881,723 | 83.98M |
| 275 | GENB | Generate Biomedicines, Inc. | 1.60B | 9.04% | 142,397 | 31.89M |
| 276 | ANIP | ANI Pharmaceuticals, Inc. | 1.60B | 3.85% | 139,111 | 883.37M |
| 277 | DMRA | Damora Therapeutics, Inc. | 1.58B | 7.73% | 119,962 | - |
| 278 | OCS | Oculis Holding AG | 1.57B | 8.23% | 150,405 | 1.51M |
| 279 | OGN | Organon & Co. | 1.53B | 3.16% | 1,468,950 | 6.22B |
| 280 | IMCR | Immunocore Holdings plc | 1.53B | 2.73% | 554,937 | 400.02M |
| 281 | TRVI | Trevi Therapeutics, Inc. | 1.53B | 6.17% | 352,057 | - |
| 282 | SGRY | Surgery Partners, Inc. | 1.52B | 2.07% | 382,454 | 3.31B |
| 283 | NTLA | Intellia Therapeutics, Inc. | 1.51B | 9.96% | 2,581,992 | 67.67M |
| 284 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.50B | 6.27% | 607,124 | -665.00K |
| 285 | MAZE | Maze Therapeutics, Inc. | 1.50B | 3.72% | 516,352 | 2.50M |
| 286 | UFPT | UFP Technologies, Inc. | 1.49B | 3.10% | 185,263 | 602.80M |
| 287 | SNDA | Sonida Senior Living, Inc. | 1.48B | 1.31% | 354,712 | 336.39M |
| 288 | OMCL | Omnicell, Inc. | 1.47B | 0.22% | 631,431 | 1.18B |
| 289 | INSP | Inspire Medical Systems, Inc. | 1.47B | 1.13% | 455,945 | 911.98M |
| 290 | IOVA | Iovance Biotherapeutics, Inc. | 1.46B | 6.78% | 6,581,927 | 263.50M |
| 291 | NUVB | Nuvation Bio Inc. | 1.45B | 4.44% | 1,749,745 | 62.90M |
| 292 | ARDX | Ardelyx, Inc. | 1.45B | 6.49% | 2,998,597 | 407.32M |
| 293 | NBTX | Nanobiotix S.A. | 1.44B | -4.02% | 60,250 | 11.93M |
| 294 | RAPP | Rapport Therapeutics, Inc. | 1.44B | 9.06% | 221,227 | - |
| 295 | PRCT | PROCEPT BioRobotics Corporation | 1.44B | 0.04% | 406,038 | 308.05M |
| 296 | PLSE | Pulse Biosciences, Inc. | 1.44B | 7.69% | 146,606 | 350.00K |
| 297 | VIR | Vir Biotechnology, Inc. | 1.44B | 6.15% | 628,267 | 68.56M |
| 298 | PRGO | Perrigo Company plc | 1.43B | 6.84% | 2,690,578 | 4.25B |
| 299 | MBX | MBX Biosciences, Inc. | 1.41B | 10.33% | 293,944 | - |
| 300 | AVAH | Aveanna Healthcare Holdings Inc. | 1.40B | 0.94% | 419,585 | 2.43B |
| 301 | ATRC | AtriCure, Inc. | 1.40B | -0.64% | 208,759 | 534.53M |
| 302 | PGNY | Progyny, Inc. | 1.39B | -0.24% | 530,533 | 1.29B |
| 303 | SVRA | Savara Inc. | 1.37B | 7.13% | 687,096 | - |
| 304 | PGEN | Precigen, Inc. | 1.34B | 16.62% | 6,947,845 | 9.68M |
| 305 | MLTX | MoonLake Immunotherapeutics | 1.33B | 9.92% | 1,685,889 | - |
| 306 | WVE | Wave Life Sciences Ltd. | 1.33B | 6.65% | 8,757,249 | 42.73M |
| 307 | GLUE | Monte Rosa Therapeutics, Inc. | 1.32B | 6.50% | 824,323 | 123.67M |
| 308 | NVAX | Novavax, Inc. | 1.32B | -0.12% | 3,878,337 | 1.12B |
| 309 | IMTX | Immatics N.V. | 1.31B | 4.95% | 89,662 | 56.67M |
| 310 | ATAI | AtaiBeckley Inc. | 1.30B | 5.00% | 1,837,279 | 4.09M |
| 311 | TNDM | Tandem Diabetes Care, Inc. | 1.30B | -3.19% | 698,589 | 1.01B |
| 312 | HROW | Harrow, Inc. | 1.29B | 4.44% | 254,182 | 272.30M |
| 313 | HCSG | Healthcare Services Group, Inc. | 1.28B | -2.25% | 170,949 | 1.84B |
| 314 | ENOV | Enovis Corporation | 1.28B | 2.81% | 400,309 | 2.25B |
| 315 | BCAX | Bicara Therapeutics Inc. | 1.27B | 2.02% | 388,078 | - |
| 316 | TSHA | Taysha Gene Therapies, Inc. | 1.27B | 8.60% | 1,428,535 | 9.77M |
| 317 | OLMA | Olema Pharmaceuticals, Inc. | 1.26B | 8.05% | 726,987 | - |
| 318 | BHVN | Biohaven Ltd. | 1.25B | 3.09% | 2,439,567 | - |
| 319 | ORIC | ORIC Pharmaceuticals, Inc. | 1.25B | 2.05% | 733,173 | - |
| 320 | NVCR | NovoCure Limited | 1.23B | 4.54% | 433,668 | 655.35M |
| 321 | IRMD | IRADIMED CORPORATION | 1.22B | 0.78% | 70,389 | 83.81M |
| 322 | CRVS | Corvus Pharmaceuticals, Inc. | 1.21B | 7.46% | 681,837 | - |
| 323 | ASTH | Astrana Health, Inc. | 1.20B | 0.04% | 162,274 | 3.18B |
| 324 | ARDT | Ardent Health, Inc. | 1.20B | 1.94% | 235,570 | 6.32B |
| 325 | ZBIO | Zenas BioPharma, Inc. | 1.14B | 5.57% | 925,380 | 10.00M |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.14B | 6.27% | 253,723 | 83.72M |
| 327 | USPH | U.S. Physical Therapy, Inc. | 1.13B | -0.26% | 68,108 | 773.34M |
| 328 | DBVT | DBV Technologies S.A. | 1.12B | 6.13% | 219,923 | 5.64M |
| 329 | NNNN | Anbio Biotechnology | 1.11B | 2.60% | 17,953 | 6.92M |
| 330 | PHAR | Pharming Group N.V. | 1.11B | 4.31% | 15,984 | 376.13M |
| 331 | QDEL | QuidelOrtho Corporation | 1.10B | 6.23% | 920,234 | 2.73B |
| 332 | ALVO | Alvotech | 1.08B | 4.86% | 320,031 | 588.90M |
| 333 | CNMD | CONMED Corporation | 1.07B | 4.02% | 236,299 | 1.37B |
| 334 | SEPN | Septerna, Inc. | 1.07B | 2.58% | 104,570 | 45.95M |
| 335 | INNV | InnovAge Holding Corp. | 1.07B | 0.13% | 117,076 | 915.37M |
| 336 | EYPT | EyePoint, Inc. | 1.06B | 7.26% | 1,032,244 | 31.37M |
| 337 | ABCL | AbCellera Biologics Inc. | 1.05B | 6.10% | 2,149,363 | 75.13M |
| 338 | PNTG | The Pennant Group, Inc. | 1.05B | 0.43% | 66,569 | 947.71M |
| 339 | IVA | Inventiva S.A. | 1.05B | 1.82% | 677,108 | 19.93M |
| 340 | COLL | Collegium Pharmaceutical, Inc. | 1.04B | 2.75% | 195,412 | 780.57M |
| 341 | BFLY | Butterfly Network, Inc. | 1.04B | 6.27% | 2,483,682 | 97.61M |
| 342 | KALV | KalVista Pharmaceuticals, Inc. | 1.03B | 9.42% | 922,905 | 73.62M |
| 343 | AVBP | ArriVent BioPharma, Inc. | 1.02B | 10.19% | 247,808 | - |
| 344 | CTMX | CytomX Therapeutics, Inc. | 1.00B | 5.22% | 1,617,773 | 76.20M |
| 345 | XERS | Xeris Biopharma Holdings, Inc. | 998.38M | 3.39% | 995,941 | 291.85M |
| 346 | SSII | SS Innovations International, Inc. | 989.70M | 0.61% | 14,509 | 42.48M |
| 347 | QURE | uniQure N.V. | 981.09M | 6.52% | 893,656 | 16.10M |
| 348 | INBX | Inhibrx Biosciences, Inc. | 968.08M | 10.68% | 98,382 | 1.30M |
| 349 | NEO | NeoGenomics, Inc. | 961.26M | 2.85% | 646,284 | 727.33M |
| 350 | AZTA | Azenta, Inc. | 949.79M | 1.83% | 554,717 | 595.03M |
| 351 | GERN | Geron Corporation | 944.80M | 4.61% | 9,823,884 | 183.88M |
| 352 | AKTS | Aktis Oncology, Inc. | 942.77M | 8.52% | 516,648 | 6.50M |
| 353 | STAA | STAAR Surgical Company | 933.81M | 2.84% | 319,370 | 239.44M |
| 354 | BLFS | BioLife Solutions, Inc. | 925.91M | 2.08% | 137,014 | 96.21M |
| 355 | TDOC | Teladoc Health, Inc. | 925.88M | 0.97% | 2,708,472 | 2.53B |
| 356 | CRON | Cronos Group Inc. | 925.60M | 3.07% | 393,496 | 146.59M |
| 357 | CMPX | Compass Therapeutics, Inc. | 923.85M | 0.59% | 2,309,847 | 850.00K |
| 358 | CLOV | Clover Health Investments, Corp. | 923.41M | 2.33% | 4,454,096 | 1.92B |
| 359 | PCRX | Pacira BioSciences, Inc. | 917.91M | -2.58% | 210,879 | 726.41M |
| 360 | CERT | Certara, Inc. | 907.89M | 0.44% | 5,797,026 | 418.84M |
| 361 | AMPH | Amphastar Pharmaceuticals, Inc. | 895.15M | 2.65% | 199,022 | 719.89M |
| 362 | XNCR | Xencor, Inc. | 888.13M | 6.70% | 558,726 | 125.58M |
| 363 | URGN | UroGen Pharma Ltd. | 883.10M | 6.71% | 256,282 | 109.79M |
| 364 | MPLT | MapLight Therapeutics, Inc. | 880.92M | 6.95% | 77,578 | - |
| 365 | ABUS | Arbutus Biopharma Corporation | 880.63M | 4.77% | 927,887 | 14.08M |
| 366 | GHRS | GH Research PLC | 877.72M | 8.60% | 139,905 | - |
| 367 | EVO | Evotec SE | 877.11M | 5.08% | 55,029 | 887.40M |
| 368 | FTRE | Fortrea Holdings Inc. | 875.16M | 5.52% | 589,280 | 2.72B |
| 369 | PHAT | Phathom Pharmaceuticals, Inc. | 874.67M | 5.41% | 375,159 | 175.11M |
| 370 | ANNX | Annexon, Inc. | 872.18M | 9.58% | 2,983,497 | - |
| 371 | INMD | InMode Ltd. | 864.85M | 1.79% | 717,561 | 370.50M |
| 372 | TALK | Talkspace, Inc. | 863.78M | -0.19% | 487,620 | 228.87M |
| 373 | CDNA | CareDx, Inc. | 863.25M | 2.59% | 304,872 | 379.81M |
| 374 | OPK | OPKO Health, Inc. | 861.54M | 3.18% | 1,301,087 | 606.88M |
| 375 | CGEM | Cullinan Therapeutics, Inc. | 847.97M | 4.40% | 313,382 | - |
| 376 | EVMN | Evommune, Inc. | 846.61M | 6.84% | 148,009 | 13.00M |
| 377 | JANX | Janux Therapeutics, Inc. | 844.34M | 6.52% | 582,390 | 10.00M |
| 378 | SDGR | Schrödinger, Inc. | 835.70M | 2.26% | 314,886 | 255.87M |
| 379 | SGP | SpyGlass Pharma, Inc. | 832.94M | 6.97% | 58,726 | - |
| 380 | TBPH | Theravance Biopharma, Inc. | 828.01M | 5.37% | 353,076 | 107.46M |
| 381 | LMRI | Lumexa Imaging Holdings, Inc. | 807.32M | 5.40% | 428,248 | 1.02B |
| 382 | SPRY | ARS Pharmaceuticals, Inc. | 798.35M | 2.88% | 733,317 | 84.28M |
| 383 | TENX | Tenax Therapeutics, Inc. | 794.75M | 12.78% | 346,438 | - |
| 384 | BIOA | BioAge Labs, Inc. | 783.30M | 11.50% | 390,262 | 9.00M |
| 385 | SANA | Sana Biotechnology, Inc. | 761.90M | 6.53% | 1,817,498 | - |
| 386 | BVS | Bioventus Inc. | 748.39M | 0.45% | 245,566 | 568.09M |
| 387 | SLS | SELLAS Life Sciences Group, Inc. | 747.96M | 4.00% | 4,935,787 | - |
| 388 | OMDA | Omada Health, Inc. | 746.59M | 5.19% | 472,904 | 260.21M |
| 389 | OMER | Omeros Corporation | 746.58M | 7.34% | 701,668 | - |
| 390 | TLRY | Tilray Brands, Inc. | 744.48M | 6.68% | 1,716,209 | 837.32M |
| 391 | MNKD | MannKind Corporation | 739.44M | 1.27% | 2,160,550 | 348.97M |
| 392 | MRVI | Maravai LifeSciences Holdings, Inc. | 726.21M | -1.91% | 1,336,640 | 185.74M |
| 393 | IART | Integra LifeSciences Holdings Corporation | 725.60M | 2.08% | 262,792 | 1.64B |
| 394 | CSTL | Castle Biosciences, Inc. | 725.14M | 3.57% | 213,446 | 344.23M |
| 395 | ANRO | Alto Neuroscience, Inc. | 721.33M | 13.01% | 455,497 | - |
| 396 | EHAB | Enhabit, Inc. | 719.26M | 0.93% | 676,880 | 1.06B |
| 397 | KURA | Kura Oncology, Inc. | 713.70M | 4.53% | 615,440 | 67.48M |
| 398 | RLMD | Relmada Therapeutics, Inc. | 713.25M | 6.58% | 1,018,476 | - |
| 399 | VOR | Vor Biopharma Inc. | 712.07M | 16.67% | 1,743,989 | - |
| 400 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 708.29M | 1.96% | 109,712 | - |
| 401 | AMN | AMN Healthcare Services, Inc. | 706.64M | -2.40% | 216,782 | 2.73B |
| 402 | CMPS | COMPASS Pathways plc | 702.63M | 4.01% | 1,009,935 | - |
| 403 | ESPR | Esperion Therapeutics, Inc. | 697.24M | 3.23% | 5,165,213 | 403.14M |
| 404 | SLDB | Solid Biosciences Inc. | 696.61M | 9.09% | 781,421 | - |
| 405 | JBIO | Jade Biosciences, Inc. | 694.37M | 6.18% | 157,620 | - |
| 406 | MGTX | MeiraGTx Holdings plc | 693.11M | 5.19% | 479,057 | 81.39M |
| 407 | CBLL | CeriBell, Inc. | 678.29M | 1.46% | 143,713 | 89.06M |
| 408 | ARVN | Arvinas, Inc. | 677.99M | 4.13% | 504,910 | 262.60M |
| 409 | PSNL | Personalis, Inc. | 674.88M | 3.37% | 1,419,328 | 69.65M |
| 410 | DRUG | Bright Minds Biosciences Inc. | 670.65M | 7.89% | 97,668 | - |
| 411 | ETON | Eton Pharmaceuticals, Inc. | 669.29M | 8.64% | 421,919 | 79.95M |
| 412 | DSGN | Design Therapeutics, Inc. | 667.29M | 4.34% | 151,715 | - |
| 413 | GDRX | GoodRx Holdings, Inc. | 661.17M | 1.05% | 815,592 | 796.85M |
| 414 | LXRX | Lexicon Pharmaceuticals, Inc. | 654.59M | 2.32% | 990,917 | 49.80M |
| 415 | NUTX | Nutex Health Inc. | 651.89M | 2.92% | 63,783 | 875.26M |
| 416 | AVNS | Avanos Medical, Inc. | 645.99M | 1.17% | 151,826 | 701.20M |
| 417 | GYRE | Gyre Therapeutics, Inc. | 635.55M | 1.75% | 55,693 | 116.59M |
| 418 | REPL | Replimune Group, Inc. | 626.73M | 5.42% | 1,078,230 | - |
| 419 | DRTS | Alpha Tau Medical Ltd. | 622.67M | 8.02% | 142,887 | - |
| 420 | LBRX | LB Pharmaceuticals Inc | 611.73M | 4.00% | 156,605 | - |
| 421 | PRME | Prime Medicine, Inc. | 610.92M | 9.52% | 1,317,371 | 4.63M |
| 422 | HSTM | HealthStream, Inc. | 606.80M | -1.99% | 141,090 | 304.06M |
| 423 | OCGN | Ocugen, Inc. | 599.77M | 1.43% | 5,070,106 | 4.41M |
| 424 | TCMD | Tactile Systems Technology, Inc. | 596.52M | 1.31% | 68,069 | 329.52M |
| 425 | ALLO | Allogene Therapeutics, Inc. | 591.16M | 9.23% | 2,555,707 | 22.00K |
| 426 | CBIO | Crescent Biopharma, Inc. | 588.05M | 6.53% | 84,949 | 10.84M |
| 427 | TECX | Tectonic Therapeutic, Inc. | 584.52M | 7.83% | 80,761 | - |
| 428 | MDXG | MiMedx Group, Inc. | 579.41M | 1.04% | 1,009,377 | 418.63M |
| 429 | EIKN | Eikon Therapeutics, Inc. | 577.09M | 10.43% | 231,416 | - |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 575.60M | 9.29% | 1,037,957 | 296.15M |
| 431 | CTKB | Cytek Biosciences, Inc. | 563.05M | 1.86% | 237,152 | 201.49M |
| 432 | SIBN | SI-BONE, Inc. | 559.57M | 3.18% | 246,376 | 200.93M |
| 433 | ZURA | Zura Bio Limited | 558.85M | 3.70% | 389,486 | - |
| 434 | VALN | Valneva SE | 556.03M | 1.78% | 264,881 | 205.07M |
| 435 | ZVRA | Zevra Therapeutics, Inc. | 539.56M | 4.67% | 453,680 | 106.47M |
| 436 | YDES | YD Bio Limited | 538.44M | -5.47% | 8,355 | 510.36K |
| 437 | CRMD | CorMedix Inc. | 538.33M | 3.65% | 411,103 | 311.71M |
| 438 | PROK | ProKidney Corp. | 531.37M | 8.64% | 990,780 | 893.00K |
| 439 | PRTA | Prothena Corporation plc | 523.26M | 5.08% | 342,618 | 9.68M |
| 440 | EMBC | Embecta Corp. | 521.73M | -0.34% | 517,007 | 1.08B |
| 441 | BWAY | BrainsWay Ltd. | 519.93M | 2.19% | 103,557 | 52.23M |
| 442 | AGMB | AgomAb Therapeutics NV | 515.15M | 7.20% | 99,438 | - |
| 443 | ACRS | Aclaris Therapeutics, Inc. | 512.89M | 5.73% | 989,100 | 7.83M |
| 444 | AQST | Aquestive Therapeutics, Inc. | 511.37M | 3.71% | 630,020 | 44.55M |
| 445 | KYTX | Kyverna Therapeutics, Inc. | 507.22M | 10.69% | 469,366 | - |
| 446 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 6.22M |
| 447 | FULC | Fulcrum Therapeutics, Inc. | 500.83M | 14.29% | 2,750,825 | 80.00M |
| 448 | RIGL | Rigel Pharmaceuticals, Inc. | 494.53M | 4.08% | 88,253 | 294.28M |
| 449 | FLGT | Fulgent Genetics, Inc. | 493.13M | 1.02% | 241,957 | 322.67M |
| 450 | VTVT | vTv Therapeutics Inc. | 490.30M | 7.66% | 32,805 | 17.00K |
| 451 | PHR | Phreesia, Inc. | 486.53M | -29.71% | 10,182,505 | 480.59M |
| 452 | AVR | Anteris Technologies Global Corp. | 486.19M | 8.61% | 498,549 | 1.91M |
| 453 | UPB | Upstream Bio, Inc. | 484.34M | 1.37% | 341,893 | 2.85M |
| 454 | NAUT | Nautilus Biotechnology, Inc. | 480.94M | 10.79% | 200,706 | - |
| 455 | CTNM | Contineum Therapeutics, Inc. | 480.89M | 3.37% | 144,233 | - |
| 456 | ADCT | ADC Therapeutics SA | 475.78M | 2.88% | 453,535 | 81.36M |
| 457 | FDMT | 4D Molecular Therapeutics, Inc. | 475.29M | 8.63% | 291,366 | 85.21M |
| 458 | KMDA | Kamada Ltd. | 475.22M | 2.60% | 37,741 | 180.46M |
| 459 | LYEL | Lyell Immunopharma, Inc. | 474.30M | 5.50% | 36,402 | 36.00K |
| 460 | LRMR | Larimar Therapeutics, Inc. | 471.63M | 5.34% | 709,997 | - |
| 461 | ANGO | AngioDynamics, Inc. | 466.17M | 4.05% | 321,796 | 307.31M |
| 462 | FBRX | Forte Biosciences, Inc. | 465.04M | -0.91% | 185,322 | - |
| 463 | CATX | Perspective Therapeutics, Inc. | 462.57M | 6.01% | 733,717 | 884.00K |
| 464 | VSTM | Verastem, Inc. | 462.01M | 8.45% | 2,409,933 | 30.91M |
| 465 | IMMX | Immix Biopharma, Inc. | 461.85M | 1.63% | 743,961 | - |
| 466 | ENGN | enGene Holdings Inc. | 458.88M | 10.84% | 100,761 | - |
| 467 | ABSI | Absci Corporation | 457.53M | 8.33% | 2,135,332 | 2.80M |
| 468 | OFIX | Orthofix Medical Inc. | 457.24M | 0.62% | 78,231 | 822.31M |
| 469 | STTK | Shattuck Labs, Inc. | 456.22M | 6.96% | 296,064 | 1.00M |
| 470 | VREX | Varex Imaging Corporation | 443.51M | 2.32% | 116,954 | 854.40M |
| 471 | NPCE | NeuroPace, Inc. | 440.70M | 1.95% | 96,363 | 99.99M |
| 472 | TRDA | Entrada Therapeutics, Inc. | 440.28M | 3.91% | 73,762 | 25.42M |
| 473 | BBNX | Beta Bionics, Inc. | 434.50M | -0.71% | 1,455,069 | 100.25M |
| 474 | ASMB | Assembly Biosciences, Inc. | 433.13M | 2.50% | 52,379 | 72.30M |
| 475 | RGNX | REGENXBIO Inc. | 429.42M | 7.08% | 303,261 | 170.44M |
| 476 | AVIR | Atea Pharmaceuticals, Inc. | 427.04M | 5.51% | 169,911 | - |
| 477 | EBS | Emergent BioSolutions Inc. | 420.90M | 1.24% | 290,549 | 742.90M |
| 478 | LXEO | Lexeo Therapeutics, Inc. | 417.85M | 7.02% | 524,110 | - |
| 479 | STRO | Sutro Biopharma, Inc. | 415.51M | 4.07% | 34,545 | 102.48M |
| 480 | MYGN | Myriad Genetics, Inc. | 414.24M | 1.61% | 441,849 | 824.50M |
| 481 | AURA | Aura Biosciences, Inc. | 411.85M | 3.55% | 158,740 | - |
| 482 | EPRX | Eupraxia Pharmaceuticals Inc. | 410.80M | 6.88% | 33,216 | - |
| 483 | IPSC | Century Therapeutics, Inc. | 407.07M | 11.58% | 635,565 | 109.16M |
| 484 | AUNA | Auna S.A. | 407.07M | 4.17% | 108,514 | 1.30B |
| 485 | ALT | Altimmune, Inc. | 398.77M | 6.42% | 1,857,762 | 41.00K |
| 486 | PACB | Pacific Biosciences of California, Inc. | 398.64M | 4.76% | 6,047,290 | 160.01M |
| 487 | KIDS | OrthoPediatrics Corp. | 394.60M | 2.70% | 101,703 | 236.35M |
| 488 | VNDA | Vanda Pharmaceuticals Inc. | 393.07M | - | 606,973 | 216.11M |
| 489 | LCTX | Lineage Cell Therapeutics, Inc. | 392.31M | 7.14% | 568,870 | 14.56M |
| 490 | CYH | Community Health Systems, Inc. | 390.89M | 1.74% | 965,608 | 12.49B |
| 491 | RCKT | Rocket Pharmaceuticals, Inc. | 385.42M | 3.05% | 2,888,029 | - |
| 492 | NRC | National Research Corporation | 385.32M | -1.17% | 18,699 | 137.39M |
| 493 | MNPR | Monopar Therapeutics Inc. | 379.14M | 6.46% | 86,381 | - |
| 494 | XFOR | X4 Pharmaceuticals, Inc. | 378.68M | 4.39% | 223,978 | 35.11M |
| 495 | SIGA | SIGA Technologies, Inc. | 377.57M | 0.19% | 551,807 | 94.57M |
| 496 | IVVD | Invivyd, Inc. | 371.61M | 10.50% | 2,064,240 | 53.43M |
| 497 | AUTL | Autolus Therapeutics plc | 369.94M | 9.45% | 2,781,055 | 51.13M |
| 498 | AKBA | Akebia Therapeutics, Inc. | 369.67M | 4.55% | 740,805 | 236.20M |
| 499 | PLYX | Polaryx Therapeutics, Inc. | 369.28M | 18.00% | 254,210 | - |
| 500 | XOMA | XOMA Royalty Corporation | 368.79M | 2.31% | 78,452 | 52.15M |